<bill session="115" type="s" number="292" updated="2019-07-16T21:20:09Z">
  <state datetime="2018-06-05">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2018-06-05"/>
  </status>
  <introduced datetime="2017-02-02"/>
  <titles>
    <title type="official" as="introduced">A bill to maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.</title>
    <title type="short" as="enacted">Childhood Cancer STAR Act</title>
    <title type="short" as="enacted">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018</title>
    <title type="short" as="passed senate">Childhood Cancer STAR Act</title>
    <title type="short" as="passed senate">Childhood Cancer STAR Act</title>
    <title type="short" as="passed senate">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018</title>
    <title type="short" as="passed senate">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018</title>
    <title type="short" as="passed house">Childhood Cancer STAR Act</title>
    <title type="short" as="passed house">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018</title>
    <title type="short" as="reported to senate">Childhood Cancer STAR Act</title>
    <title type="short" as="reported to senate">Childhood Cancer STAR Act</title>
    <title type="short" as="reported to senate">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2017</title>
    <title type="short" as="reported to senate">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018</title>
    <title type="short" as="reported to senate">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018</title>
    <title type="short" as="introduced">Childhood Cancer STAR</title>
    <title type="short" as="introduced">Childhood Cancer STAR Act</title>
    <title type="short" as="introduced">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2017</title>
    <title type="short" as="introduced">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2017</title>
    <title type="display">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018</title>
  </titles>
  <sponsor bioguide_id="R000122"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2018-03-07"/>
    <cosponsor bioguide_id="B001267" joined="2018-02-28"/>
    <cosponsor bioguide_id="B001277" joined="2017-05-18"/>
    <cosponsor bioguide_id="B000575" joined="2017-03-21"/>
    <cosponsor bioguide_id="B001288" joined="2017-05-03"/>
    <cosponsor bioguide_id="B000944" joined="2018-01-08"/>
    <cosponsor bioguide_id="C001047" joined="2017-02-02"/>
    <cosponsor bioguide_id="C000141" joined="2018-03-07"/>
    <cosponsor bioguide_id="C001070" joined="2017-06-05"/>
    <cosponsor bioguide_id="C001075" joined="2017-05-18"/>
    <cosponsor bioguide_id="C001035" joined="2017-05-03"/>
    <cosponsor bioguide_id="C001088" joined="2017-05-03"/>
    <cosponsor bioguide_id="C001113" joined="2018-02-28"/>
    <cosponsor bioguide_id="C000880" joined="2018-03-19"/>
    <cosponsor bioguide_id="D000607" joined="2018-02-28"/>
    <cosponsor bioguide_id="D000622" joined="2018-02-05"/>
    <cosponsor bioguide_id="E000295" joined="2017-09-14"/>
    <cosponsor bioguide_id="F000062" joined="2018-02-28"/>
    <cosponsor bioguide_id="F000463" joined="2017-10-25"/>
    <cosponsor bioguide_id="F000457" joined="2017-10-25"/>
    <cosponsor bioguide_id="G000555" joined="2017-04-25"/>
    <cosponsor bioguide_id="G000386" joined="2017-05-15"/>
    <cosponsor bioguide_id="H001076" joined="2018-03-22"/>
    <cosponsor bioguide_id="H000338" joined="2018-01-30"/>
    <cosponsor bioguide_id="H001041" joined="2018-02-08"/>
    <cosponsor bioguide_id="I000055" joined="2017-02-02"/>
    <cosponsor bioguide_id="J000300" joined="2018-03-15"/>
    <cosponsor bioguide_id="K000384" joined="2018-02-28"/>
    <cosponsor bioguide_id="K000393" joined="2017-05-15"/>
    <cosponsor bioguide_id="K000383" joined="2017-05-03"/>
    <cosponsor bioguide_id="K000367" joined="2018-02-14"/>
    <cosponsor bioguide_id="L000174" joined="2018-02-28"/>
    <cosponsor bioguide_id="M001183" joined="2017-09-12"/>
    <cosponsor bioguide_id="M000133" joined="2018-02-08"/>
    <cosponsor bioguide_id="M000303" joined="2018-03-20"/>
    <cosponsor bioguide_id="M000639" joined="2018-03-22"/>
    <cosponsor bioguide_id="M001176" joined="2018-02-28"/>
    <cosponsor bioguide_id="M001153" joined="2018-02-05"/>
    <cosponsor bioguide_id="M001111" joined="2018-03-21"/>
    <cosponsor bioguide_id="N000032" joined="2017-09-14"/>
    <cosponsor bioguide_id="P000612" joined="2017-05-03"/>
    <cosponsor bioguide_id="P000595" joined="2018-01-30"/>
    <cosponsor bioguide_id="P000449" joined="2017-09-14"/>
    <cosponsor bioguide_id="R000584" joined="2018-03-22"/>
    <cosponsor bioguide_id="R000595" joined="2017-04-25"/>
    <cosponsor bioguide_id="S000033" joined="2018-03-05"/>
    <cosponsor bioguide_id="S000148" joined="2018-02-28"/>
    <cosponsor bioguide_id="S001181" joined="2017-03-27"/>
    <cosponsor bioguide_id="S001203" joined="2018-02-28"/>
    <cosponsor bioguide_id="S000770" joined="2017-05-15"/>
    <cosponsor bioguide_id="T000476" joined="2018-02-28"/>
    <cosponsor bioguide_id="V000128" joined="2017-02-02"/>
    <cosponsor bioguide_id="W000802" joined="2017-05-15"/>
    <cosponsor bioguide_id="W000437" joined="2018-02-14"/>
    <cosponsor bioguide_id="Y000064" joined="2017-06-05"/>
  </cosponsors>
  <actions>
    <action datetime="2017-02-02">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-02-02" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S659" label="Sponsor introductory remarks on measure"/>
    </action>
    <calendar datetime="2018-02-28" state="REPORTED">
      <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </calendar>
    <action datetime="2018-03-12">
      <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2018-03-12" calendar="Senate Legislative" under="General Orders" number="342">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 342.</text>
    </calendar>
    <vote how="by Unanimous Consent" type="vote" datetime="2018-03-22" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment by Unanimous Consent.</text>
      <reference ref="CR S1975-1977" label="consideration"/>
      <reference ref="CR S1975-1977" label="text of measure as reported in Senate"/>
    </vote>
    <action datetime="2018-03-23">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2018-03-26T16:01:45-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2018-03-26">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-03-30">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-05-22T15:22:34-04:00">
      <text>Mr. Burgess moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2018-05-22T15:22:50-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H4349-4355" label="consideration"/>
    </action>
    <action datetime="2018-05-22T15:23:00-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on S. 292.</text>
    </action>
    <vote how="by voice vote" type="vote2" datetime="2018-05-22T15:51:37-04:00" where="h" result="pass" state="PASSED:BILL">
      <text>On motion to suspend the rules and pass the bill Agreed to by voice vote.</text>
      <reference ref="CR H4350-4352" label="text"/>
    </vote>
    <action datetime="2018-05-22T15:51:39-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <topresident datetime="2018-05-24">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2018-06-05" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="115-180" type="public" datetime="2018-06-05">
      <text>Became Public Law No: 115-180.</text>
    </enacted>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="identical" number="820"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Cancer"/>
    <term name="Child health"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health care quality"/>
    <term name="Health information and medical records"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Home and outpatient care"/>
    <term name="Long-term, rehabilitative, and terminal care"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Mental health"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Research administration and funding"/>
    <term name="Social work, volunteer service, charitable organizations"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-06T03:59:58Z" status="Public Law">Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 or the Childhood Cancer STAR Act

TITLE I--MAXIMIZING RESEARCH THROUGH DISCOVERY

Subtitle A--Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (Sec. 101) This bill amends the Public Health Service Act to authorize the National Institutes of Health (NIH) to provide support to collect the medical specimens and information of children, adolescents, and young adults with selected cancers that have the least effective treatments in order to achieve a better understanding of these cancers and the effects of treatment.

(Sec. 102) The national childhood cancer registry is reauthorized through FY2023 and revised to authorize the Centers for Disease Control and Prevention to award grants to state cancer registries to improve tracking of childhood cancers.

Subtitle B--Pediatric Expertise at NIH

(Sec. 111) The bill requires at least one member of the National Cancer Advisory Board, which advises the National Cancer Institute, to be knowledgeable in pediatric oncology.

Subtitle C--NIH Reporting on Childhood Cancer Activities

(Sec. 121) The NIH must ensure that information about supported childhood cancer research projects is included in appropriate congressional reports, including the Pediatric Research Initiative report.

TITLE II--MAXIMIZING DELIVERY: CARE, QUALITY OF LIFE, SURVIVORSHIP, AND CAREGIVER SUPPORT

(Sec. 201) The Department of Health and Human Services (HHS) may support pilot programs to develop or study models for monitoring and caring for childhood cancer survivors throughout their lives.

HHS must also review departmental activities relating to workforce development for health care providers who treat pediatric cancer patients and survivors.

(Sec. 202) The NIH may continue to support research relating to pediatric cancer survivorship, including outcomes for, and barriers faced by, pediatric cancer survivors within minority or medically underserved populations.

(Sec. 203) HHS may also support the development of best practices regarding childhood and adolescent cancer survivorship care.</summary>
  <committee-reports/>
</bill>
